Sandra Ros
Overview
Explore the profile of Sandra Ros including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lobo-Prat D, Sainz L, Laiz A, de Dios A, Fontcuberta L, Fernandez S, et al.
J Eval Clin Pract
. 2024 Sep;
PMID: 39253893
Introduction: Integrated care pathways (ICPs) are crucial for delivering individualised care. However, the development of ICPs is challenging and must be well designed to provide the expected benefits. Regarding this,...
2.
Figueras I, Feito M, Garcia-Bustinduy M, Monte-Boquet E, Ros S, Zaragoza V, et al.
Acta Derm Venereol
. 2024 Apr;
104:adv18255.
PMID: 38566531
Atopic dermatitis is a cutaneous inflammatory disease characterized by intense pruritus, which is often underestimated despite its direct impact on patients' health-related quality of life and the high burden it...
3.
Bergamo S, Trape J, Gonzalez-Garcia L, Gonzalez-Fernandez C, Vergara C, de-la-Torre N, et al.
Clin Biochem
. 2023 Sep;
120:110645.
PMID: 37696320
Background And Aims: Human epididymal protein 4 (HE4) may be a useful tool in the differential diagnosis of malignant ascites. The aim of this study was to evaluate the diagnostic...
4.
Maravilla-Herrera P, Merino M, Alfonso Zamora S, Balea Filgueiras J, Carrascosa Carrillo J, Delgado Sanchez O, et al.
Front Public Health
. 2023 Feb;
11:1000776.
PMID: 36778548
Introduction: Psoriasis is a chronic disease involving the skin, which significantly impacts the quality of life. Disease severity and treatment efficacy (i.e., response) are assessed through the Psoriasis Area and...
5.
Zozaya N, Abdalla F, Alfonso Zamora S, Balea Filgueiras J, Carrascosa Carrillo J, Delgado Sanchez O, et al.
Expert Rev Pharmacoecon Outcomes Res
. 2022 Apr;
22(6):941-953.
PMID: 35404728
Background: Multi-criteria decision analysis (MCDA) was proposed to surmount arbitrary clinical decisions in the field of biological therapies for psoriatic patients. At the same time, MCDA may further highlight the...
6.
Zozaya N, Villoro R, Abdalla F, Alfonso Zamora S, Balea Filgueiras J, Carrascosa Carrillo J, et al.
Acta Derm Venereol
. 2022 Mar;
102:adv00678.
PMID: 35312022
Psoriasis is a chronic, systemic inflammatory disease that affects the skin, with a high impact on patients' quality of life. The aim of this study was to identify and determine...
7.
Trape J, Sant F, Montesinos J, Arnau A, Sala M, Bernadich O, et al.
Anticancer Res
. 2019 Sep;
39(9):5071-5076.
PMID: 31519617
Background/aim: Approximately 20% of pleural effusions are associated with cancer; about 50% require invasive procedures to perform diagnosis. Determination of the concentration of soluble cytokeratin 19-fragments (CYFRA21-1) may help identify...
8.
Yelamos O, Ros S, Puig L
Psoriasis (Auckl)
. 2018 Feb;
5:109-115.
PMID: 29387587
Psoriasis is a frequent inflammatory disease with a chronic and relapsing course. Therefore, patients with psoriasis are likely to undergo different treatments for long periods of time. Traditionally, therapies used...
9.
Trape J, Sant F, Franquesa J, Montesinos J, Arnau A, Sala M, et al.
Respir Res
. 2017 May;
18(1):103.
PMID: 28545517
Background: Pleural effusions present a diagnostic challenge. Approximately 20% are associated with cancer and some 50% require invasive procedures to perform diagnosis. Determination of tumour markers may help to identify...
10.
Sustained response to tocilizumab in a patient with relapsing polychondritis complicated by aortitis
Salles M, Minguez S, Ros S, Tuneu R, Gelman S
Clin Exp Rheumatol
. 2017 Feb;
35 Suppl 103(1):223.
PMID: 28229816
No abstract available.